Virtual Mindfulness and Weight Management to Mitigate Risk of Relapse and Improve Wellbeing in Cancer Survivors
A Virtual Mindfulness and Weight Management Program for Those With Cancer Histories to Mitigate Risk of Relapse and Improve Wellbeing: A Feasibility Study
2 other identifiers
interventional
19
1 country
1
Brief Summary
This clinical trial tests how well a virtual mindfulness and weight management program to mitigate risk of relapse and improve well being for obese cancer survivors in community practice and rural areas. Obesity has been linked to increased risk for certain kinds of cancer and is the second highest modifiable risk factor for cancer. It is also well documented that having a cancer diagnosis and treatment is a stressful experience. It is hoped that an addition of a 10-minute mindfulness-based stress reduction exercise to the virtual positive health habits group focused on weight management can improve wellbeing and distress. Virtual care options continue to extend the reach of medical providers to cancer survivors, particularly those in the rural setting. A virtual behavioral weight management program with an integrated mindfulness component may improve mood, coping strategies, stress management, and weight loss among community practice and rural obese cancer survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 28, 2023
CompletedStudy Start
First participant enrolled
September 8, 2023
CompletedFirst Posted
Study publicly available on registry
September 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 2, 2024
CompletedOctober 24, 2025
November 1, 2024
4 months
August 28, 2023
October 22, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
General anxiety disorder-7 (GAD-7)
Assessed by change in GAD-7 scores from a total score for seven items ranges from 0 to 21: 0-4 (minimal anxiety); 5-9 (mild anxiety); 10-14 (moderate anxiety); 15-21 (severe anxiety).
Baseline; 12 weeks
Patient Health Questionnaire (PHQ)-8
Assessed by change in PHQ-8 scores, as measured by a total score of 4 items from 0-12: 0-2 (normal); 3-5 (mild depression); 6-8 (moderate depression); 9-12 (severe depression).
Baseline; 12 weeks
Feasibility of virtual mindfulness and weight management program
Assessed by the extent to which participants adhere to the intervention. Will be quantified based on number of sessions attended out of a possible 12.
12 weeks
Secondary Outcomes (4)
Body weight
Baseline; 12 weeks
Body composition parameter
Baseline; 12 weeks
Daily activity levels - heart rate
Baseline; 12 weeks
Daily activity levels - activity
Baseline; 12 weeks
Study Arms (1)
Supportive care (virtual mindfulness and weight management)
EXPERIMENTALPatients participate in a virtual behavioral weight management program with an integrated mindfulness component consisting of 12, 75-minute virtual group sessions over 12 weeks to help improve mood, coping strategies, stress management, and weight loss. Patents also receive patient education handouts, view behavioral educational PowerPoint presentations over 30 minutes, and wear a Fitbit on study.
Interventions
Participate in weight management program
Receive patient education handouts
View behavioral educational PowerPoint presentation
Complete virtual behavioral weight management with an integrated mindfulness component program
Wear Fitbit
Complete mindfulness components
Ancillary studies
Ancillary studies
Eligibility Criteria
You may qualify if:
- or over
- Identified stage I, II, or III cancer in remission
- Body mass index (BMI) of 30 or greater
- English as a primary language
- Has access to a device with a camera (computer, tablet, or video capable phone) that has wifi and reliable internet access
You may not qualify if:
- Unable to provide consent
- Eastern Cooperative Oncology Group (ECOG) performance status scale score of 3 or above
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic Health System-Franciscan Healthcare
La Crosse, Wisconsin, 54601, United States
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa Howell, Ph.D.
Mayo Clinic Health System-Franciscan Healthcare
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 28, 2023
First Posted
September 11, 2023
Study Start
September 8, 2023
Primary Completion
January 2, 2024
Study Completion
January 2, 2024
Last Updated
October 24, 2025
Record last verified: 2024-11